Mar 26 |
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
|
Mar 26 |
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
|
Mar 25 |
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
|
Mar 20 |
Puma Biotech cleared to trial Takeda-partnered breast cancer therapy in U.S.
|
Mar 19 |
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
|
Mar 19 |
Centogene, Takeda extend diagnostic partnership
|
Mar 19 |
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
|